• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一部分稳定的非进展性1型HIV感染者中存在强烈的细胞毒性T细胞反应和较弱的中和抗体反应。

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection.

作者信息

Harrer T, Harrer E, Kalams S A, Elbeik T, Staprans S I, Feinberg M B, Cao Y, Ho D D, Yilma T, Caliendo A M, Johnson R P, Buchbinder S P, Walker B D

机构信息

AIDS Research Center and Infectious Disease Unit, Massachusetts General Hospital, Boston, USA.

出版信息

AIDS Res Hum Retroviruses. 1996 May 1;12(7):585-92. doi: 10.1089/aid.1996.12.585.

DOI:10.1089/aid.1996.12.585
PMID:8743084
Abstract

Some individuals in well-defined cohorts have now been infected with HIV-1 for well over a decade and yet remain clinically asymptomatic with normal CD4 counts. To determine immunologic and virologic parameters in these individuals, we examined 10 persons from the San Francisco City Clinic with firmly documented infection of 11-15 years duration who had maintained stable CD4 counts above 500 cells/microliters. Our results indicate that long-term nonprogressors are a heterogeneous group with respect to viral load and HIV-1-specific immune responses, and that progression can occur even after 15 years of stable infection. However, in a subset of persons with the lowest viral loads and persistent nonprogressive infection, we detected strong CTL responses, whereas neutralizing antibody studies revealed weak to undetectable titers against a panel of 10 primary isolates. This study demonstrates that a vigorous in vivo activated HIV-1-specific CTL response can be part of the host immune response in stable nonprogressive HIV-1 infection, and that circulating activated CTL can be detected in the setting of an extremely low viral load. These results also indicate that long-term nonprogressing HIV-1 infection does not require the presence of broadly cross-reactive neutralizing antibodies.

摘要

在明确界定的队列中,一些个体感染HIV-1已超过十年,但临床上仍无症状,CD4细胞计数正常。为了确定这些个体的免疫和病毒学参数,我们检查了来自旧金山城市诊所的10名患者,他们有确切记录的感染时间为11至15年,且CD4细胞计数一直稳定在500个/微升以上。我们的结果表明,长期不进展者在病毒载量和HIV-1特异性免疫反应方面是一个异质性群体,并且即使在稳定感染15年后仍可能发生疾病进展。然而,在病毒载量最低且持续无进展感染的一部分患者中,我们检测到了强烈的CTL反应,而针对一组10种原始病毒株的中和抗体研究显示滴度较弱或无法检测到。这项研究表明,在稳定的无进展HIV-1感染中,活跃的体内激活的HIV-1特异性CTL反应可以是宿主免疫反应的一部分,并且在极低病毒载量的情况下可以检测到循环激活的CTL。这些结果还表明,长期无进展的HIV-1感染并不需要广泛交叉反应的中和抗体的存在。

相似文献

1
Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection.在一部分稳定的非进展性1型HIV感染者中存在强烈的细胞毒性T细胞反应和较弱的中和抗体反应。
AIDS Res Hum Retroviruses. 1996 May 1;12(7):585-92. doi: 10.1089/aid.1996.12.585.
2
Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.无症状长期非进展性HIV-1感染中的细胞毒性T淋巴细胞。一名长期感染且病毒载量低的患者的免疫反应广度和特异性及其与体内病毒准种的关系。
J Immunol. 1996 Apr 1;156(7):2616-23.
3
Studies in subjects with long-term nonprogressive human immunodeficiency virus infection.对长期非进展性人类免疫缺陷病毒感染受试者的研究。
N Engl J Med. 1995 Jan 26;332(4):209-16. doi: 10.1056/NEJM199501263320402.
4
Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors.1型人类免疫缺陷病毒感染的长期不进展者中的中和逃逸
J Infect Dis. 1999 May;179(5):1264-7. doi: 10.1086/314711.
5
Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors.在1型人类免疫缺陷病毒(HIV-1)感染的长期存活者中,1型人类免疫缺陷病毒特异性细胞毒性T淋巴细胞活性与HIV-1病毒载量呈负相关。
AIDS Res Hum Retroviruses. 1999 Sep 1;15(13):1219-28. doi: 10.1089/088922299310313.
6
Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection.原发性感染和长期非进展性感染中针对1型人类免疫缺陷病毒的中和抗体反应。
J Infect Dis. 1997 Oct;176(4):924-32. doi: 10.1086/516508.
7
Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression.长期不进展者中效应性HIV特异性细胞毒性T淋巴细胞活性:与病毒复制及疾病进展的关联
J Med Virol. 2003 Dec;71(4):483-91. doi: 10.1002/jmv.10525.
8
Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection--correlation with clinical progression, viral load, and loss of humoral immunity.1型人类免疫缺陷病毒感染期间CD4+和CD19+细胞的凋亡——与临床进展、病毒载量及体液免疫丧失的相关性
Virology. 1997 Nov 24;238(2):180-8. doi: 10.1006/viro.1997.8790.
9
Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infection.在对HIV感染进行长期、成功的药物治疗期间,HIV特异性中和抗体选择性增加,细胞免疫反应部分重建。
AIDS Res Hum Retroviruses. 2001 Jul 20;17(11):1021-34. doi: 10.1089/088922201300343708.
10
Neutralizing antibodies against autologous human immunodeficiency virus Type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment.尽管抗逆转录病毒治疗期间病毒抑制不完全,但CD4细胞计数不断增加的患者体内针对自体人类免疫缺陷病毒1型分离株的中和抗体。
Clin Diagn Lab Immunol. 2001 Jul;8(4):822-4. doi: 10.1128/CDLI.8.4.822-824.2001.

引用本文的文献

1
Energy demanding RNA and protein metabolism drive dysfunctionality of HIV-specific T cell changes during chronic HIV infection.高耗能的RNA和蛋白质代谢导致慢性HIV感染期间HIV特异性T细胞变化的功能失调。
PLoS One. 2024 Oct 2;19(10):e0298472. doi: 10.1371/journal.pone.0298472. eCollection 2024.
2
Nucleic Acid Vaccines Encoding Proteins and Virus-like Particles for HIV Prevention.用于预防HIV的编码蛋白质和病毒样颗粒的核酸疫苗。
Vaccines (Basel). 2024 Mar 12;12(3):298. doi: 10.3390/vaccines12030298.
3
Definition of a New HLA B*52-Restricted Rev CTL Epitope Targeted by an HIV-1-Infected Controller.
定义一个新的 HLA B*52 限制的 Rev CTL 表位,该表位由 HIV-1 感染者的控制者靶向。
Viruses. 2023 Feb 18;15(2):567. doi: 10.3390/v15020567.
4
Clinical and Laboratory Outcomes in HIV-1 and HTLV-1/2 Coinfection: A Systematic Review.HIV-1 和 HTLV-1/2 合并感染的临床和实验室结果:系统评价。
Front Public Health. 2022 Mar 7;10:820727. doi: 10.3389/fpubh.2022.820727. eCollection 2022.
5
Preventive HIV Vaccines-Leveraging on Lessons from the Past to Pave the Way Forward.预防性HIV疫苗——借鉴过往经验,铺就前行道路。
Vaccines (Basel). 2021 Sep 8;9(9):1001. doi: 10.3390/vaccines9091001.
6
Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection.多供体纵向抗体库测序揭示了 HIV-1 感染中公共抗体克隆型的存在。
Cell Host Microbe. 2018 Jun 13;23(6):845-854.e6. doi: 10.1016/j.chom.2018.05.001. Epub 2018 May 31.
7
Advances in HIV-1 Vaccine Development.HIV-1 疫苗研发进展。
Viruses. 2018 Apr 1;10(4):167. doi: 10.3390/v10040167.
8
In vitro inhibition of HIV-1 replication in autologous CD4 T cells indicates viral containment by multifactorial mechanisms.在自体 CD4 T 细胞中抑制 HIV-1 复制的体外实验表明,多因素机制可控制病毒。
Virol Sin. 2017 Dec;32(6):485-494. doi: 10.1007/s12250-017-3992-9. Epub 2017 Sep 15.
9
Evasion of adaptive immunity by HIV through the action of host APOBEC3G/F enzymes.HIV通过宿主载脂蛋白B mRNA编辑酶催化多肽样3G/F(APOBEC3G/F)酶的作用逃避适应性免疫。
AIDS Res Ther. 2017 Sep 12;14(1):44. doi: 10.1186/s12981-017-0173-8.
10
HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategies.面向非洲的艾滋病毒/艾滋病疫苗:科学机遇、挑战与策略
Pan Afr Med J. 2015 Apr 20;20:386. doi: 10.11604/pamj.2015.20.386.4660. eCollection 2015.